Skip to content

Rhenman & Partners Asset Management AB 13F Holdings · Q2 2026

Rhenman & Partners Asset Management AB reported 99 securities worth $1.06B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: UNH (3.67%), CVS (2.73%), AZN (2.69%). Among its top 25 positions this quarter: 4 new, 12 added, 9 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1UNHUNITED HEALTH GROUP INC$38.9M3.67%93,600Added
2CVSCVS HEALTH CORP$28.9M2.73%279,374Trimmed
3AZNASTRAZENECA PLC$28.5M2.69%151,500New
4MRKMERCK & CO INC$27.4M2.59%213,500New
5LLYLILLY ELI & CO$26.8M2.53%22,315Trimmed
6ABBVABBVIE INC$24.4M2.30%96,775Added
7ALHCALIGNMENT HEALTHCARE INC$23.7M2.24%997,083Trimmed
8EWEDWARDS LIFESCIENCES CORP$23.5M2.22%260,000Added
9GILDGILEAD SCIENCES INC$22.5M2.13%178,250Added
10JAZZJAZZ PHARMACEUTICALS PLC$21.1M1.99%87,440Added
11BIIBBIOGEN INC$20.5M1.93%94,850Trimmed
12SYKSTRYKER CORPORATION$20.5M1.93%65,000Added
13BSXBOSTON SCIENTIFIC CORP$19.2M1.81%450,500Trimmed
14JNJJOHNSON & JOHNSON$18.4M1.74%72,500New
15GHGUARDANT HEALTH INC$17.3M1.63%115,000Trimmed
16REGNREGENERON PHARMACEUTICALS$17.1M1.61%27,390Trimmed
17BMRNBIOMARIN PHARMACEUTICAL INC$16.6M1.57%290,500Added
18GKOSGLAUKOS CORP$16.6M1.57%119,000Added
19NRIXNURIX THERAPEUTICS INC$16.6M1.57%684,250Added
20NTRANATERA INC$16.6M1.56%61,050Added
21MIRMMIRUM PHARMACEUTICALS INC$16.3M1.54%139,205Added
22INSMINSMED INC$16.2M1.53%151,960Trimmed
23THCTENET HEALTHCARE CORP$15.9M1.50%85,200Added
24TMOTHERMO FISHER SCIENTIFIC INC$15.8M1.49%31,580Trimmed
25CNCCENTENE CORP DEL$15.7M1.48%244,000New

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR